Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Pulmonary Hypertension

  Free Subscription


03.08.2026

1 Am J Case Rep
1 Bioengineering (Basel)
1 BMC Cardiovasc Disord
1 BMC Pregnancy Childbirth
1 Br J Cardiol
1 Catheter Cardiovasc Interv
1 Chest
1 Clin J Am Soc Nephrol
1 Clin Transl Sci
1 Echocardiography
1 Eur Heart J
1 Eur Heart J Imaging Methods Pract
1 Eye (Lond)
1 Front Immunol
1 Hypertension
1 Immunohorizons
1 J Am Coll Cardiol
1 J Am Heart Assoc
1 J Cardiovasc Dev Dis
2 J Heart Lung Transplant
1 J Matern Fetal Neonatal Med
1 J Nucl Cardiol
1 J Occup Environ Med
1 J Perinatol
1 J Thorac Cardiovasc Surg
1 J Thromb Thrombolysis
1 JACC Case Rep
1 JCI Insight
1 JHLT Open
2 Medicina (Kaunas)
1 Mol Biol Rep
1 Open Med (Wars)
13 Pulm Circ
1 Respir Med Res
1 Respir Res
1 Respiration
1 Semin Hematol
1 Turk J Med Sci


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Case Rep

  1. NWOKEOCHA SO, Abduova L, Thiruvarudchelvam S, Chaudhary A, et al
    Pre-Capillary Pulmonary Hypertension in a Patient With Idiopathic Inflammatory Myopathy Without Extensive Pulmonary Involvement.
    Am J Case Rep. 2026;27:e953110.
    PubMed         Abstract available


    Bioengineering (Basel)

  2. QI Y, Ma K, Han X, Xu D, et al
    Temporal Convolutional Neural Network Analysis of Magnetocardiography Signals for Detection of Pulmonary Hypertension.
    Bioengineering (Basel). 2026;13:736.
    PubMed         Abstract available


    BMC Cardiovasc Disord

  3. YU Q, Zhao Y, Huang Y, Zhang M, et al
    Identification of pulmonary hypertension with pulmonary vascular surface volume ratio by non-contrast CT.
    BMC Cardiovasc Disord. 2026;26:641.
    PubMed         Abstract available


    BMC Pregnancy Childbirth

  4. LU XT, Chen XR, Jin Q, Xu YY, et al
    Maternal and fetal outcomes in patients with congenital heart disease associated with pulmonary arterial hypertension in high-altitude areas: a retrospective cohort study.
    BMC Pregnancy Childbirth. 2026;26:818.
    PubMed         Abstract available


    Br J Cardiol

  5. MOHIADDIN H, Mohee K, Ambrogetti R, Bhandari SS, et al
    Does severe pulmonary hypertension affect long-term survival after TAVI for severe aortic stenosis?
    Br J Cardiol. 2026;33:003.
    PubMed         Abstract available


    Catheter Cardiovasc Interv

  6. KUCUK M, Zablah JE, Fleming G, Vanloozen D, et al
    Performance of the Occlutech(R) Atrial Flow Regulator Device in Patients With Either Failing Fontan Circulations or Irreversible Pulmonary Hypertension.
    Catheter Cardiovasc Interv. 2026 Jul 26. doi: 10.1002/ccd.70776.
    PubMed         Abstract available


    Chest

  7. DAGAN M, Nanayakkara S, Chan W, Beale A, et al
    Pulmonary Hypertension Under the Microscope: What Histopathology Means for Diagnosis and Treatment.
    Chest. 2026 Jul 28:S0012-3692(26)06312-9. doi: 10.1016/j.chest.2026.07.5215.
    PubMed         Abstract available


    Clin J Am Soc Nephrol

  8. TUTTLE M, Ruopp NF, Sarnak MJ
    Pulmonary Hypertension, Right Ventricular Remodeling and Outcomes in Chronic Kidney Disease.
    Clin J Am Soc Nephrol. 2026 Jul 27. doi: 10.2215/CJN.0000001198.
    PubMed         Abstract available


    Clin Transl Sci

  9. AYALASOMAYAJULA S, Bajwa EK, Cornell AG, Loureiro MJ, et al
    The Evolving Landscape of Pulmonary Hypertension Treatment: From Vasodilation to Disease Modification.
    Clin Transl Sci. 2026;19:e70685.
    PubMed         Abstract available


    Echocardiography

  10. GHERBESI E, Faggiano A, Cuspidi C
    The Electrocardiogram and Pulmonary Hypertension: When Occam'S Razor Fails.
    Echocardiography. 2026;43:e70577.
    PubMed        


    Eur Heart J

  11. CHEN Z, Ge D, Li X, Wei TW, et al
    AMPK/USP10 loop activation of ACE2: implications for pulmonary hypertension.
    Eur Heart J. 2026 Jul 28:ehag568. doi: 10.1093.
    PubMed         Abstract available


    Eur Heart J Imaging Methods Pract

  12. JUMATATE R, Labaf A, Ingvarsson A, Johansson M, et al
    Right ventricular longitudinal function is associated with exercise capacity in pre-capillary pulmonary hypertension: a multimodality imaging study.
    Eur Heart J Imaging Methods Pract. 2026;4:qyag116.
    PubMed         Abstract available


    Eye (Lond)

  13. SHE W, She M, Sun T
    Comment on: 'Systemic prostacyclin analogues in pulmonary hypertension are associated with reduced risk of age-related macular degeneration: a cohort study'.
    Eye (Lond). 2026 Jul 31. doi: 10.1038/s41433-026-04378.
    PubMed        


    Front Immunol

  14. LAMA E, Wang Y, Wu J, Ma Q, et al
    Pathophysiological mechanisms and therapeutic potential of E-selectin in pulmonary arterial hypertension.
    Front Immunol. 2026;17:1754940.
    PubMed         Abstract available


    Hypertension

  15. HUANG C, Bai J, Luo A, Yang L, et al
    Omaveloxolone Driven NRF2 Activation as a Novel Therapeutic Strategy for Pulmonary Hypertension.
    Hypertension. 2026 Jul 27. doi: 10.1161/HYPERTENSIONAHA.126.26711.
    PubMed         Abstract available


    Immunohorizons

  16. VILLANUEVA LM, Ito H, Qi X, Chapoval SP, et al
    Absence of insulin receptor substrate 2 (IRS2) in myeloid cells results in enhanced hypoxia-induced remodeling of the pulmonary vasculature and heart with modest effects on allergic lung inflammation.
    Immunohorizons. 2026;10:vlag028.
    PubMed         Abstract available


    J Am Coll Cardiol

  17. REDDY YNV, Frantz RP, Miranda WR, Harada T, et al
    Sotatercept in Pulmonary Arterial Hypertension: Central, Hematologic, and Peripheral Mechanisms of Benefit.
    J Am Coll Cardiol. 2026 Mar 2:S0735-1097(26)05633.
    PubMed         Abstract available


    J Am Heart Assoc

  18. LUO XY, Li XC, Fu X, Tian YY, et al
    Endoplasmic Reticulum Stress-Induced Endothelial Cell Pyroptosis Contributes to Pulmonary Vascular Remodeling and Pulmonary Arterial Hypertension via IRE1alpha/Caspase-3/GSDME Pathway.
    J Am Heart Assoc. 2026;15:e043577.
    PubMed         Abstract available


    J Cardiovasc Dev Dis

  19. YE Y, Wang H, Lan Y, Pan W, et al
    Uric Acid-to-Albumin Ratio as a Complementary Biomarker for In-Hospital Risk Stratification in Patients with Pulmonary Hypertension: A Retrospective Cohort Study.
    J Cardiovasc Dev Dis. 2026;13:295.
    PubMed         Abstract available


    J Heart Lung Transplant

  20. DOROBANTU DM, van de Bruaene A, Budts W, Cifra B, et al
    Sports and Supervised Exercise Programmes for Children and Young Adults with Pulmonary Hypertension. 2026 Consensus Statement from the European Pediatric Pulmonary Vascular Disease Network (EPPVDN) and the Association for European Paediatric and Conge
    J Heart Lung Transplant. 2026 Jul 29:S1053-2498(26)02015.
    PubMed         Abstract available

  21. WU Y, Deng YR, Cui XP, Zhu SS, et al
    Misdiagnosed as Idiopathic PAH: Methylmalonic Acidemia as a Reversible Cause of Pediatric Pulmonary Hypertension.
    J Heart Lung Transplant. 2026 Jul 25:S1053-2498(26)02005.
    PubMed         Abstract available


    J Matern Fetal Neonatal Med

  22. ZHONG D, Gao W, Ren J, Yang L, et al
    Vasoactive-Inotropic Score and in-hospital mortality in preterm infants < 34 weeks' gestation with early pulmonary hypertension in the setting of respiratory distress and sepsis.
    J Matern Fetal Neonatal Med. 2026;39:2705051.
    PubMed         Abstract available


    J Nucl Cardiol

  23. MUKHERJEE M, Hassoun PM
    Metabolism beyond mechanics: Revisiting right ventricular adaptation in pulmonary hypertension.
    J Nucl Cardiol. 2026;61:102792.
    PubMed        


    J Occup Environ Med

  24. ZINELLU E, Piras B, Di Lorenzo B, Albrahimi E, et al
    A Retrospective Analysis of Risk Factors for Respiratory Failure in Silicosis Patients Exposed to Granite Dust.
    J Occup Environ Med. 2026;68:e560-e564.
    PubMed         Abstract available


    J Perinatol

  25. PHAD N, Woodford R, de Waal K
    Left ventricular diastolic dysfunction in preterm infants with bronchopulmonary dysplasia.
    J Perinatol. 2026 Jun 1. doi: 10.1038/s41372-026-02715.
    PubMed         Abstract available


    J Thorac Cardiovasc Surg

  26. KUMAR U, Chiu S, Chia A, Varzaly J, et al
    Safety and efficacy of a dedicated pulmonary thromboendarterectomy fellowship: The Royal Papworth experience at a high-volume center.
    J Thorac Cardiovasc Surg. 2026;172:404-412.
    PubMed         Abstract available


    J Thromb Thrombolysis

  27. OMUR SE, Zorlu C, Karayakali M, Karaman K, et al
    Admission electrocardiographic markers of atrial cardiomyopathy predict persistent pulmonary hypertension and chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: a retrospective cohort study.
    J Thromb Thrombolysis. 2026 Jul 31. doi: 10.1007/s11239-026-03375.
    PubMed         Abstract available


    JACC Case Rep

  28. WANG L, Cui Y, Song J, Zhao Q, et al
    Pseudo-Infarction Reversal in Right Precordial Leads: ECG Evolution in Severe Pulmonary Hypertension.
    JACC Case Rep. 2026;31:109342.
    PubMed         Abstract available


    JCI Insight

  29. MICKAEL C, Fonseca Balladares DC, Kumar R, Lee MH, et al
    Role of CD4 T cell mannose binding lectin in Schistosoma-induced pulmonary hypertension.
    JCI Insight. 2026 Jul 28:e202919. doi: 10.1172/jci.insight.202919.
    PubMed         Abstract available


    JHLT Open

  30. GUIMARON S, Mercier J, Hautbergue T, Ruffenach G, et al
    Right ventricular remodeling and circulating metabolic profiles of patients with chronic thromboembolic pulmonary hypertension before and after pulmonary endarterectomy.
    JHLT Open. 2026;13:100618.
    PubMed         Abstract available


    Medicina (Kaunas)

  31. KARKOULIAS S, Leontsinis I, Iliakis P, Kallenou L, et al
    Repurposing Heart Failure Therapies in Pulmonary Arterial Hypertension: Mechanistic Rationale, Translational Evidence, and Clinical Perspectives for SGLT2 Inhibitors and Mineralocorticoid Receptor Antagonists.
    Medicina (Kaunas). 2026;62:1345.
    PubMed         Abstract available

  32. HU L, Zhao Q, Zhao Z, Luo Q, et al
    Retrospective Evaluation of Recombinant Human Brain Natriuretic Peptide Therapy for Decompensated Right Heart Failure Across Pulmonary Hypertension Groups.
    Medicina (Kaunas). 2026;62:1213.
    PubMed         Abstract available


    Mol Biol Rep

  33. LIANG J, Xie Y, Su D, Pang Y, et al
    Post-translational modification crosstalk in pulmonary arterial hypertension: mechanisms and therapeutic implications.
    Mol Biol Rep. 2026;53:1308.
    PubMed         Abstract available


    Open Med (Wars)

  34. HUANG A, Pan T, Gao Y, Ji G, et al
    Construction of nomogram for predicting pulmonary hypertension on echocardiography in chronic obstructive pulmonary disease: a single-center retrospective study.
    Open Med (Wars). 2026;21:20261475.
    PubMed         Abstract available


    Pulm Circ

  35. MOREL KC, Sood N, Bernardo R, Jackson K, et al
    Navigating the Complexities of Pulmonary Hypertension Care: Unique Challenges in PAH Management.
    Pulm Circ. 2026;16:e70340.
    PubMed         Abstract available

  36. RAWLINGS GH, Armstrong I, Thompson AR, Kiely DG, et al
    Getting the Wheels in Motion to Deal With Unmet Psychological Need: A Reply to "The Pulmonary Hypertension Global Patient Survey: Physical and Psychosocial Impacts on Health-Related Quality of Life".
    Pulm Circ. 2026;16:e70356.
    PubMed        

  37. ALQARNI AA, Aljedani RH, Aldhahir AM, Alasimi AH, et al
    The Therapeutic Efficacy of Drugs Targeting the NO-sGC-cGMP Pathway in Treatment of Patients With Chronic Thromboembolic Pulmonary Hypertension: A Systematic Review.
    Pulm Circ. 2026;16:e70337.
    PubMed         Abstract available

  38. KARIM R, Fyrdahl A, Ramos JG, Melin M, et al
    The Relationship Between Vortical Flow and Pressure Gradient Reversal in Pulmonary Hypertension-A 4D Analysis of Cardiovascular Magnetic Resonance Flow Imaging.
    Pulm Circ. 2026;16:e70350.
    PubMed         Abstract available

  39. CHEN K, Li L, Huang Y, Ye L, et al
    The Role of Piezo Ion Channels in Pulmonary Hypertension.
    Pulm Circ. 2026;16:e70360.
    PubMed         Abstract available

  40. YUE J, Wang P, Liu H, Pei H, et al
    Poncirin Alleviates Hypoxic Pulmonary Hypertension by Blocking TDP43-Mediated Macrophage Pyroptosis.
    Pulm Circ. 2026;16:e70368.
    PubMed         Abstract available

  41. MCGARRITY S, Johansson PI, Carlsen J
    Metabolic Markers as Potential Risk Factors in Pulmonary Hypertension.
    Pulm Circ. 2026;16:e70342.
    PubMed         Abstract available

  42. REISER AE, Thiersch M, Gassmann M, Schneider SR, et al
    Iron Homeostasis at High Altitude in Patients With Pulmonary Hypertension.
    Pulm Circ. 2026;16:e70352.
    PubMed         Abstract available

  43. RAJAGOPAL S, Abueg J, Hart KM, Lau E, et al
    Activin Signaling Inhibitors in Pulmonary Hypertension: A State-of-the-Art Review.
    Pulm Circ. 2026;16:e70353.
    PubMed         Abstract available

  44. SUZUKI Y, Nakano Y, Okazaki K, Ito M, et al
    Long-Term Supervised Cardiac Rehabilitation After Balloon Pulmonary Angioplasty Improved Residual Exercise Pulmonary Hypertension in Patients With Chronic Thromboembolic Pulmonary Hypertension: A Two-Case Report.
    Pulm Circ. 2026;16:e70359.
    PubMed         Abstract available

  45. DAGHER C, Moallem N, Fiscus G, Carollo B, et al
    Noninvasive Gas Exchange Determinants of Exercise Hemodynamics in Non-Severe Pulmonary Hypertension Associated With Interstitial Lung Disease.
    Pulm Circ. 2026;16:e70358.
    PubMed         Abstract available

  46. YOGESWARAN A, Funderich M, Wendlandt K, Annis JS, et al
    Angiotensin Converting Enzyme Inhibition and Mortality in Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease (PH-COPD).
    Pulm Circ. 2026;16:e70348.
    PubMed         Abstract available

  47. LUO X, Xiong X, Li J, Luo J, et al
    The Level and Clinical Significance of Red Blood Cell Distribution Width in Patients With Congenital Heart Disease Associated With Pulmonary Hypertension.
    Pulm Circ. 2026;16:e70339.
    PubMed         Abstract available


    Respir Med Res

  48. DUIJNHOUWER AL, Hagmolen Of Ten Have W, Van Haren-Willems J, Knaapen-Hans H, et al
    Apparent nonadherence to risk-guided therapy in pulmonary hypertension: The role of clinical complexity in real-world practice.
    Respir Med Res. 2026;90:101306.
    PubMed         Abstract available


    Respir Res

  49. HARUTYUNOVA S, Heinz J, Benjamin N, Bruckner L, et al
    Effects of riociguat on right ventricular size and function in pulmonary arterial hypertension (RIVER II): a prospective, phase IV study.
    Respir Res. 2026;27:296.
    PubMed         Abstract available


    Respiration

  50. KAMENSKI-RATHMANNER T, Tornyos A, Brcic L, Talakic E, et al
    Pulmonary hypertension in patients with moderate to severe hypersensitivity pneumonitis.
    Respiration. 2026 Jul 29:1-19. doi: 10.1159/000553575.
    PubMed         Abstract available


    Semin Hematol

  51. D'HUMIERES T, Jeune SL, de Luna G, Moulin T, et al
    The many facets of cardiopulmonary complications in sickle cell disease.
    Semin Hematol. 2026;63:16-27.
    PubMed         Abstract available


    Turk J Med Sci

  52. MERC P, Demir R, Zeren M, Durdu H, et al
    Reliability and validity of the Turkish version of the Barthel Index-dyspnea in patients with pulmonary hypertension.
    Turk J Med Sci. 2026;56:794-800.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Pulmonary Hypertension is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum